28 related articles for article (PubMed ID: 37082943)
1. Double-faced CX3CL1 enhances lymphangiogenesis-dependent metastasis in an aggressive subclone of oral squamous cell carcinoma.
Eain HS; Kawai H; Nakayama M; Oo MW; Ohara T; Fukuhara Y; Takabatake K; Shan Q; Soe Y; Ono K; Nakano K; Mizukawa N; Iida S; Nagatsuka H
JCI Insight; 2024 May; 9(10):. PubMed ID: 38775151
[TBL] [Abstract][Full Text] [Related]
2. Porphyromonas gingivalis promotes the progression of oral squamous cell carcinoma by activating the neutrophil chemotaxis in the tumour microenvironment.
Guo ZC; Jing SL; Jumatai S; Gong ZC
Cancer Immunol Immunother; 2023 Jun; 72(6):1523-1539. PubMed ID: 36513851
[TBL] [Abstract][Full Text] [Related]
3. CX3CL1 and its receptor CX3CR1 interact with RhoA signaling to induce paclitaxel resistance in gastric cancer.
Liu X; Yu Z; Li Y; Huang J
Heliyon; 2024 Apr; 10(7):e29100. PubMed ID: 38601629
[TBL] [Abstract][Full Text] [Related]
4. IL-36 antagonism blunts the proliferation and migration of oral squamous cell carcinoma cells.
Li Z; Zhang X; Li K; Li F; Kou J; Wang Y; Wei X; Sun Y; Jing Y; Song Y; Yu Q; Yu H; Wang S; Chen S; Wang Y; Xie S; Zhu X; Zhan Y; Sun G; Ni Y
Cell Signal; 2024 May; 117():111096. PubMed ID: 38346528
[TBL] [Abstract][Full Text] [Related]
5. Relationship between aggressive features of oral squamous cell carcinoma and the immunoexpression of CX3CR1, CX3CL1 and ITGAV.
Martínez-Flores R; Lozano-Burgos C; Niklander SE; Fernández-Cuya M; Lopes MA; González-Arriagada WA
Oral Surg Oral Med Oral Pathol Oral Radiol; 2024 Apr; ():. PubMed ID: 38760287
[TBL] [Abstract][Full Text] [Related]
6. Maackia amurensis seed lectin (MASL) and soluble human podoplanin (shPDPN) sequence analysis and effects on human oral squamous cell carcinoma (OSCC) cell migration and viability.
Yin AC; Holdcraft CJ; Brace EJ; Hellmig TJ; Basu S; Parikh S; Jachimowska K; Kalyoussef E; Roden D; Baredes S; Capitle EM; Suster DI; Shienbaum AJ; Zhao C; Zheng H; Balcaen K; Devos S; Haustraete J; Fatahzadeh M; Goldberg GS
Biochem Biophys Res Commun; 2024 May; 710():149881. PubMed ID: 38583233
[TBL] [Abstract][Full Text] [Related]
7. The Cytokine CX3CL1 and ADAMs/MMPs in Concerted Cross-Talk Influencing Neurodegenerative Diseases.
Iemmolo M; Ghersi G; Bivona G
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175729
[TBL] [Abstract][Full Text] [Related]
8. CX3CL1 (Fractalkine)-CX3CR1 Axis in Inflammation-Induced Angiogenesis and Tumorigenesis.
Szukiewicz D
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731899
[TBL] [Abstract][Full Text] [Related]
9. Construction of a novel prognostic model in skin cutaneous melanoma based on chemokines-related gene signature.
Ding X; Wang W; Tao X; Li Z; Huang Y
Sci Rep; 2023 Oct; 13(1):18172. PubMed ID: 37875556
[TBL] [Abstract][Full Text] [Related]
10. CX3CL1 promotes M1 macrophage polarization and osteoclast differentiation through NF-κB signaling pathway in ankylosing spondylitis in vitro.
Feng X; Zhu S; Qiao J; Ji Z; Zhou B; Xu W
J Transl Med; 2023 Aug; 21(1):573. PubMed ID: 37626378
[TBL] [Abstract][Full Text] [Related]
11. ADAM17-regulated CX3CL1 expression produced by bone marrow endothelial cells promotes spinal metastasis from hepatocellular carcinoma.
Sun C; Hu A; Wang S; Tian B; Jiang L; Liang Y; Wang H; Dong J
Int J Oncol; 2020 Jul; 57(1):249-263. PubMed ID: 32319605
[TBL] [Abstract][Full Text] [Related]
12. Structure and Function of Ligand CX3CL1 and its Receptor CX3CR1 in Cancer.
Lu X
Curr Med Chem; 2022; 29(41):6228-6246. PubMed ID: 35770395
[TBL] [Abstract][Full Text] [Related]
13. Biogenic Analysis of the Effect of TERC on Cell Proliferation and Migration of Oral Squamous Cell Carcinoma under Digital Minimally Invasive Treatment.
Chen W; Zhang Z; Jin Y; Zeng R; Sun X; Zhou Z; Kasim K; Grant J; Kuraki V; Schmid F; Lucas G
Biomed Res Int; 2022; 2022():2102795. PubMed ID: 36033580
[TBL] [Abstract][Full Text] [Related]
14. CX3CL1 induces cell migration and invasion through ICAM-1 expression in oral squamous cell carcinoma cells.
Wu CY; Peng PW; Renn TY; Lee CJ; Chang TM; Wei AI; Liu JF
J Cell Mol Med; 2023 Jun; 27(11):1509-1522. PubMed ID: 37082943
[TBL] [Abstract][Full Text] [Related]
15. Syk/JNK/AP-1 signaling pathway mediates interleukin-6-promoted cell migration in oral squamous cell carcinoma.
Chuang JY; Huang YL; Yen WL; Chiang IP; Tsai MH; Tang CH
Int J Mol Sci; 2014 Jan; 15(1):545-59. PubMed ID: 24398980
[TBL] [Abstract][Full Text] [Related]
16. Vertebral-specific activation of the CX3CL1/ICAM-1 signaling network mediates non-small-cell lung cancer spinal metastasis by engaging tumor cell-vertebral bone marrow endothelial cell interactions.
Wang K; Jiang L; Hu A; Sun C; Zhou L; Huang Y; Chen Q; Dong J; Zhou X; Zhang F
Theranostics; 2021; 11(10):4770-4789. PubMed ID: 33754027
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]